Brand Name(s):Priligy

Indication:Premature ejaculation (PE) in adult men aged 18 to 64 years



Review Date:Jan-25

Patients should be referred to the Sexual Dysfunction Clinic (commissioned from Leger Clinic or Urology DBH FT) for assessment of PE. If appropriate for drug treatment a first prescription will be issued by the Specialist service, who will then assess response to treatment and establish future management plan. If there is a requirement for ongoing prescriptions these should then be provided by Primary Care.

July 2014
Dapoxetine may be prescribed for patients who fulfill the following criteria as per it’s licensed indication:
Priligy is indicated for the treatment of premature ejaculation (PE) in adult men aged 18 to 64 years.

Priligy should only be prescribed to patients who meet all the following criteria:

* An intravaginal ejaculatory latency time (IELT) of less than two minutes; and

* Persistent or recurrent ejaculation with minimal sexual stimulation before, on, or shortly after penetration and before the patient wishes; and

* Marked personal distress or interpersonal difficulty as a consequence of PE; and

* Poor control over ejaculation; and

* A history of premature ejaculation in the majority of intercourse attempts over the prior 6 months.

Priligy should be administered only as on-demand treatment before anticipated sexual activity. Priligy should not be prescribed to delay ejaculation in men who have not been diagnosed with PE

SPC Priligy November 2013